Successful life sciences portfolio building already in early phases

Insights, News

24th February 2021
2020 was an extraordinary year for venture capital investors in life sciences.
In his new blog article, our Principal Sven Eppert from the Managed Partner Funds writes about the background of this development, the influence of AI and Big Data, the collaboration of strong partners in the scene and more.
Press enter or esc to cancel